Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 10
Submit an article Journal homepage
147
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Quality of life in hypertension management using olmesartan in primary care

André C Schmidt Charité – Universitätsmedizin Berlin, Department of Clinical Pharmacology and Toxicology, CharitéCentrum für Therapieforschung, Charitéplatz 1, D-10117 Berlin, Germany +49 33708 928068; +49 33708 928069; [email protected]; Charité – Universitätsmedizin Berlin, Department of Medicine, Out-patient Clinic, CharitéCentrum für Innere Medizin und Dermatologie, Germany
,
Peter Bramlage Technical University Dresden, Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Dresden, Germany
,
Roger Limberg Berlin-Chemie AG, Medicine & Research, Cardiovascular Department, Berlin, Germany
&
Reinhold Kreutz Charité – Universitätsmedizin Berlin, Department of Clinical Pharmacology and Toxicology, CharitéCentrum für Therapieforschung, Charitéplatz 1, D-10117 Berlin, Germany +49 33708 928068; +49 33708 928069; [email protected]; Charité – Universitätsmedizin Berlin, Department of Medicine, Out-patient Clinic, CharitéCentrum für Innere Medizin und Dermatologie, Germany
Pages 1641-1653 | Published online: 21 Jun 2008

Bibliography

  • Kullman S, Svardsudd K. Differences in perceived symptoms/quality of life in untreated hypertensive and normotensive men. Scand J Prim Health Care 1990;1:47-53
  • Battersby C, Hartley K, Fletcher AF, et al. Quality of life in treated hypertension: a case-control community based study. J Hum Hypertens 1995;9(12):981-6
  • Schoenberger JA, Croog SH, Sudilovsky A, et al. Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group. Am J Hypertens 1990;3(2):123-32
  • Siegrist J, Matschinger H, Motz W. Untreated hypertensives and their quality of life. J Hypertens Suppl 1987;5(1):S15-20
  • Kjellgren KI, Ahlner J, Dahlof B, et al. Perceived symptoms amongst hypertensive patients in routine clinical practice – a population-based study. J Intern Med 1998;244(4):325-32
  • Muller A, Montoya P, Schandry R, Hartl L. Changes in physical symptoms, blood pressure and quality of life over 30 days. Behav Res Ther 1994;32(6):593-603
  • Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118(8):622-9
  • Fitzpatrick R, Fletcher A, Gore S, et al. Quality of life measures in health care. I. Applications and issues in assessment. BMJ 1992;305(6861):1074-7
  • Weinberger M, Kirkman MS, Samsa GP, et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 1994;32(12):1173-81
  • Beto JA, Bansal VK. Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Am J Hypertens 1992;5(3):125-33
  • Cote I, Gregoire JP, Moisan J, Chabot I. Quality of life in hypertension: the SF-12 compared to the SF-36. Can J Clin Pharmacol 2004;11(2):e232-8
  • Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34(3):220-33
  • Pickard AS, Johnson JA, Penn A, et al. Replicability of SF-36 summary scores by the SF-12 in stroke patients. Stroke 1999;30(6):1213-7
  • Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess 2003;7(31):1-94
  • Oparil S, Williams D, Chrysant SG, et al. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens (Greenwich) 2001;3(5):283-91, 318
  • Schmidt AC, Bramlage P, Lichtenthal A, et al. Socio-economic status and the therapeutic effectiveness of antihypertensive treatment – the design of the LEO study. Curr Med Res Opin 2007;23(8):1987-95
  • Barrios V, Boccanelli A, Ewald S, et al. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study. Clin Drug Invest 2007;27(8):545-58
  • Charles JA, Jotkowitz S, Byrd LH. Prevention of migraine with olmesartan in patients with hypertension/prehypertension. Headache 2006;46(3):503-7
  • Bullinger M and Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Hogrefe Verlag, Göttingen; 1998
  • Ellert U, Bellach BM. Der SF-36 im Bundes-Gesundheitssurvey – Beschreibung einer aktuellen Normstichprobe [SF-36 Questionnaire in the Federal Health Survey – Description]. Gesundheitswesen 1999;61(Suppl 2):184-90
  • Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003;289(19):2560-71
  • Sharma AM, Wittchen HU, Kirch W, et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004;22(3):479-86
  • Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43(1):10-7
  • Thamm M. Blood pressure in Germany – current status and trends. Gesundheitswesen 1999;61:S90-3
  • Conlin PR, Gerth WC, Fox J, et al. Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther 2001;23(12):1999-2010
  • Tedesco MA, Ratti G, Mennella S, et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens 1999;12(11 Pt 1):1130-4
  • Van Bortel LM, Bulpitt CJ, Fici F. Quality of life and antihypertensive effect with nebivolol and losartan. Am J Hypertens 2005;18(8):1060-6
  • Rake EC, Breeze E, Fletcher AE. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo. J Hum Hypertens 2001;15(12):863-7
  • Badia X, Gutierrez F, Wiklund I, Alonso J. Validity and reliability of the Spanish version of the Psychological General Well-Being Index. Qual Life Res 1996;5(1):101-8
  • Weber MA, Bakris GL, Neutel JM, et al. Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker. J Clin Hypertens (Greenwich) 2003;5(5):322-9
  • Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314(26):1657-64
  • Kochar M, Guthrie R, Triscari J, et al. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension. Am J Hypertens 1999;12(8 Pt 1):797-805
  • Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens 2002;16(8):569-75
  • Erkens JA, Panneman MM, Klungel OH, et al. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf 2005;14(11):795-803
  • Bramlage P, Pittrow D, Kirch W. The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary care. Curr Med Res Opin 2004;20(10):1625-31
  • Wiklund I, Halling K, Ryden-Bergsten T, Fletcher A. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press 1997;6(6):357-64
  • Weir MR, Prisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens 1996;9(9):854-9
  • Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998;20(4):671-81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.